O. Patey

Quality and Safety Requirements for Sustainable Phage Therapy Products

Jean‐Paul Pirnay, Bob Blasdel, Laurent Bretaudeau et al. · Pharmaceutical Research · 2015 · 262 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus–associated lipodystrophy syndrome

Éric Ledru, N. Christeff, O. Patey et al. · Blood · 2000 · 174 citations

Life Sciences, Immunology, Infectious Diseases +13

Unusual Neurologic Manifestations Occurring during Dengue Fever Infection

O. Patey, L. Ollivaud, J. Breuil et al. · American Journal of Tropical Medicine and Hygiene · 1993 · 118 citations

Medicine, Infectious Diseases, Neurology +17

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

Beatriz Grinsztejn, Nathalie De Castro, Vincent Arnold et al. · The Lancet Infectious Diseases · 2014 · 98 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study

Karen Champenois, Anthony Cousien, Lise Cuzin et al. · BMC Infectious Diseases · 2013 · 95 citations · Full text

Public Health, Internal Medicine, Clinical Epidemiology +15